Start Date
March 31, 1998
Primary Completion Date
September 30, 1999
Study Completion Date
September 30, 1999
Nelfinavir mesylate
Lamivudine
Stavudine
Zidovudine
Didanosine
St Luke Roosevelt Hosp, New York
UCT International, Farmingdale
St Mary's Hosp (Univ of Rochester/Infectious Diseases), Rochester
Stephen P Hauptman, Philadelphia
GW Med Ctr / Clinical Trials Unit, Washington D.C.
Nalle Clinic / Clinical Research Dept, Charlotte
Med Univ of South Carolina / Div of Infect Disease, Charleston
Specialty Med Care Ctrs of South Florida Inc, Miami
Med Alternatives, Fort Lauderdale
Urgent Care Ctr, Fort Lauderdale
Hillsborough County Health Dept, Tampa
Saint Josephs Hosp, Tampa
Sorra Research Ctr / Med Forum, Birmingham
Northwestern Univ / Div of Infect Diseases, Chicago
Rush Presbyterian / ST Lukes Med Ctr, Chicago
Univ of Kansas School of Medicine / Office of Rsch, Wichita
Associates in Med and Mental Health, Tulsa
Joseph C Gathe, Houston
Body Positive, Phoenix
UCLA Med Ctr / CARE BH-412 CHS, Los Angeles
West Los Angeles VAMC, Los Angeles
Harbor UCLA Med Ctr / Research and Educational Institute, Torrance
Sherman Oaks Hosp Research Institute, Sherman Oaks
Hill Top Research Inc, Fresno
SUNY at Stony Brook / Div of Infectious Disease, Stony Brook
Ky Clinic Annex #4 / Room 205E / Speed Sort #0284, Lexington
Univ of Texas / Med Branch at Galveston, Galveston
AIDS Healthcare Foundation, Los Angeles
Yale New Haven Hosp / Nathan Smith Clinic, New Haven
Dartmouth-Hitchcock Med Ctr, Lebanon
NJCRI, Newark
Infectious Disease Assoc of Central Jersey, Somerville
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY